BBC0403 is a selective BRD2 inhibitor that inhibits BRD2 and BRD2, suppressing NF-kappaB and MAPK signaling pathways. It can be used in osteoarthritis (OA) research.
Molecular Weight:
382.41
Purity:
98.15%
CAS Number:
[2644662-83-7]
Formula:
C21H22N2O5
Target:
Epigenetic Reader Domain
T88118
* VAT and and shipping costs not included. Errors and price changes excepted